Course Description

Ovarian cancer is a serious and under-recognized threat to women’s health. Ovarian cancer kills more women than all other gynecologic tumors combined and it is the fourth leading cause of cancer death among women in Europe. Ovarian cancer occurs in 1 in 57 women. This course is dedicated to an indepth in discussion of the best diagnostic and care option for the comprehensive management of patients with ovarian cancer. The educational program is directed primarily toward gynecologic oncologists, medical oncologists, radiologists and fellows interested in ovarian cancer.

The format of the course will include didactic sessions from a panel of expert scientists who will also discuss emerging methods for diagnosing and treating ovarian cancer. The newest developments in ovarian cancer will be discussed. Question-and-answer panel discussions will allow participants to interact with the faculty.

We do hope that participants will remember this course of the Mediterranean School of Oncology as a highlight of up to date training in the field of ovarian cancer.

FRIDAY, October 5

Presentation of the course
(S. Iacobelli, Chieti)

10.30 – 13.00Diagnostic issues and early detection
(C. Marth, Innsbruck) go to slides

Management of borderline ovarian tumors
(E. Sartori, Brescia)

Primary surgery, interval surgery and second look
(S. Greggi, Naples) go to slides

Minimally invasive surgery for ovarian cancer
(E. Vizza, Rome)

13.00 - 14.00 LUNCH

14.00 - 16.00

There is a role for neoadjuvant chemotherapy for advanced ovarian cancer?
(P. Benedetti-Panici, Rome) go to slides

Adjuvant chemotherapy
(N. Colombo, Milan) go to slides

Chemotherapy of the advanced stages
(A. Gadducci, Pisa) go to slides

Maintenance - consolidation strategies for relapsing patients with advanced ovarian cancer
(A. Gadducci, Pisa) go to slides

16.00 - 17.00
Case presentation with audience presentation and polling

SATURDAY, October 6

9.00-12.00

Dose-dense therapy and new schedules for advanced ovarian cancer
(V. Adamo, Messina) go to slides

Hereditary breast and ovarian cancer
(A. Russo, Palermo) go to slides

Intraperitoneal chemotherapy in patients with ovarian cancer
(C. Marth, Innsbruck) go to slides

Surveillance of patients after initial treatment of ovarian cancer
(A. Gadducci, Pisa) go to slides

Novel therapeutic approaches
(S. Pignata, Naples) go to slides

12.00 - 12.30
General Discussion & Conclusion

FACULTY

Vincenzo Adamo
University of Messina
Messina, Italy

Pierluigi Benedetti Panici
Campus Biomedico University
Rome, Italy

Nicoletta Colombo
European Institute of Oncology
Milan, Italy

Pierfranco Conte
University Hospital of Modena
Modena, Italy

Angiolo Gadducci
Santa Chiara Hospital
Pisa, Italy

Stefano Greggi
National Cancer Institute Fondazione Pascale
Naples, Italy

Christian Marth
Innsbruck Medical University
Innsbruck, Austria

Sandro Pignata
National Cancer Institute Fondazione Pascale
Naples, Italy

Antonio Russo
University of Palermo
Palermo, Italy

Enrico Sartori
University of Brescia
Brescia, Italy

Enrico Vizza
National Cancer Institute Regina Elena
Rome, Italy